Why the study?
Do Qianyang Yuyin Granules improve clinical efficacy and senescence markers in elderly hypertensive patients?
RCT (n=40)
Randomized
Do Qianyang Yuyin Granules improve clinical efficacy and senescence markers in elderly hypertensive patients?
Qianyang Yuyin Granules added to standard antihypertensive therapy may improve clinical efficacy and modulate energy, inflammation, and aging markers in elderly hypertensive patients.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Fang et al. (2025) conducted an RCT in Hypertension (n=40). Qianyang Yuyin Granules vs. Standard antihypertensive treatment (ARBs or CCBs) was evaluated on Clinical efficacy (effective rate) (p=<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: